Literature DB >> 11845287

Identification of members of the Wnt signaling pathway in the embryonic pituitary gland.

K R Douglas1, M L Brinkmeier, J A Kennell, P Eswara, T A Harrison, A I Patrianakos, B S Sprecher, M A Potok, R H Lyons, O A MacDougald, S A Camper.   

Abstract

Prop1 is one of several transcription factors important for the development of the pituitary gland. Downstream targets of PROP1 and other critical pituitary transcription factors remain largely unknown. We have generated a partial expression profile of the developing pituitary gland containing over 350 transcripts, using cDNA subtractive hybridization between Prop1(df/df) and wild-type embryonic pituitary gland primordia. Numerous classes of genes including transcription factors, membrane associated molecules, and cell cycle regulators were identified in this study. Of the transcripts, 34% do not have sequence similarity to known genes, but are similar to ESTs, and 4% represent novel sequences. Pituitary gland expression of a number of clones was verified using in situ hybridization. Several members of the Wnt signaling pathway were identified in the developing pituitary gland. The frizzled2 receptor, Apc, beta-catenin, groucho, and a novel isoform of TCF4 (officially named Tcf7l2) were identified in developing pituitary libraries. Three N-terminal alternatively spliced Tcf7l2 isoforms are reported here, each of which lacks a DNA-binding domain. Functional studies indicate that these isoforms can act as endogenous inhibitors of Wnt signaling in some contexts. This is the first report of Tcf7l2 and Fzd2 expression in the developing pituitary. These molecules may be important in mediating Wnt signaling during pituitary ontogeny. We expect other transcripts from these libraries to be involved in pituitary gland development.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11845287     DOI: 10.1007/s00335-001-2076-0

Source DB:  PubMed          Journal:  Mamm Genome        ISSN: 0938-8990            Impact factor:   2.957


  30 in total

Review 1.  From panhypopituitarism to combined pituitary deficiencies: do we need the anterior pituitary?

Authors:  Catherine Carrière; Anatoli Gleiberman; Chijen R Lin; Michael G Rosenfeld
Journal:  Rev Endocr Metab Disord       Date:  2004-03       Impact factor: 6.514

2.  Patterns of gene expression in pituitary carcinomas and adenomas analyzed by high-density oligonucleotide arrays, reverse transcriptase-quantitative PCR, and protein expression.

Authors:  Katharina H Ruebel; Alexey A Leontovich; Long Jin; Gail A Stilling; Heyu Zhang; Xiang Qian; Nobuki Nakamura; Bernd W Scheithauer; Kalman Kovacs; Ricardo V Lloyd
Journal:  Endocrine       Date:  2006-06       Impact factor: 3.633

3.  A high mobility group box-containing transcription factor leads to diabetes risk.

Authors:  Friedrich C Luft
Journal:  J Mol Med (Berl)       Date:  2006-11-08       Impact factor: 4.599

4.  Hes1 is required for pituitary growth and melanotrope specification.

Authors:  Lori T Raetzman; Jennifer X Cai; Sally A Camper
Journal:  Dev Biol       Date:  2006-11-10       Impact factor: 3.582

Review 5.  Molecular mechanisms of pituitary organogenesis: In search of novel regulatory genes.

Authors:  S W Davis; F Castinetti; L R Carvalho; B S Ellsworth; M A Potok; R H Lyons; M L Brinkmeier; L T Raetzman; P Carninci; A H Mortensen; Y Hayashizaki; I J P Arnhold; B B Mendonça; T Brue; S A Camper
Journal:  Mol Cell Endocrinol       Date:  2009-12-16       Impact factor: 4.102

6.  Genetic variation in thyroid folliculogenesis influences susceptibility to hypothyroidism-induced hearing impairment.

Authors:  Amanda H Mortensen; Qing Fang; Michelle T Fleming; Thomas J Jones; Alexandre Z Daly; Kenneth R Johnson; Sally A Camper
Journal:  Mamm Genome       Date:  2019-02-18       Impact factor: 2.957

7.  Premature differentiation and aberrant movement of pituitary cells lacking both Hes1 and Prop1.

Authors:  Ashley D Himes; Lori T Raetzman
Journal:  Dev Biol       Date:  2008-11-01       Impact factor: 3.582

8.  T-cell factor 4N (TCF-4N), a novel isoform of mouse TCF-4, synergizes with beta-catenin to coactivate C/EBPalpha and steroidogenic factor 1 transcription factors.

Authors:  Jennifer A Kennell; Erin E O'Leary; Brian M Gummow; Gary D Hammer; Ormond A MacDougald
Journal:  Mol Cell Biol       Date:  2003-08       Impact factor: 4.272

9.  Cellular corepressor TLE2 inhibits replication-and-transcription- activator-mediated transactivation and lytic reactivation of Kaposi's sarcoma-associated herpesvirus.

Authors:  Zhiheng He; Yunhua Liu; Deguang Liang; Zhuo Wang; Erle S Robertson; Ke Lan
Journal:  J Virol       Date:  2009-11-25       Impact factor: 5.103

10.  Alternative splicing of Tcf7l2 transcripts generates protein variants with differential promoter-binding and transcriptional activation properties at Wnt/beta-catenin targets.

Authors:  Andreas Weise; Katja Bruser; Susanne Elfert; Britta Wallmen; Yvonne Wittel; Simon Wöhrle; Andreas Hecht
Journal:  Nucleic Acids Res       Date:  2009-12-30       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.